{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:59:20Z","timestamp":1788026360044,"version":"build-2784847793"},"reference-count":44,"publisher":"The Endocrine Society","issue":"1","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Childhood overnutrition is associated with increased growth and bone mineral density (BMD) vs the opposite for undernutrition. The role of insulin receptor (InsR) signaling in these phenotypes is unclear. Rare disease patients with hyperinsulinemia and impaired InsR function (homozygous [\u2212\/\u2212] or heterozygous [+\/\u2212] INSR pathogenic variants, type B insulin resistance [TBIR]) model decreased InsR signaling, while patients with intact InsR function (congenital generalized lipodystrophy, CGL) model increased InsR signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This work aimed to understand mechanisms whereby InsR signaling influences growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional comparison was conducted of CGL (N = 23), INSR\u2212\/\u2212 (N = 13), INSR+\/\u2212 (N = 17), and TBIR (N = 8) at the National Institutes of Health. Main outcome measures included SD scores (SDS) for height, body mass index, insulin-like growth factor (IGF)-1, and BMD, and IGF binding proteins (IGFBP)-1 and -3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>INSR-\/\u2212 vs CGL had higher insulin (median 266 [222-457] vs 33 [15-55] mcU\/mL), higher IGFBP-1 (72 350 [55 571-103 107] vs 6453 [1634-26 674] pg\/mL), lower BMI SDS (\u22120.7 \u00b1 1.1 vs 0.5 \u00b1 0.9), lower height SDS (\u22121.9[\u22124.3 to \u22121.3] vs 1.1 [0.5-2.5]), lower BMD SDS (\u22121.9 \u00b1 1.4 vs 1.9 \u00b1 0.7), and lower IGFBP-3 (0.37 [0.19-1.05] vs 2.00 [1.45-2.67] \u03bcg\/mL) (P &amp;lt; .05 for all). INSR +\/\u2212 were variable. Remission of TBIR lowered insulin and IGFBP-1, and increased IGF-1 and IGFBP-3 (P &amp;lt; .05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with hyperinsulinemia and impaired InsR function exhibit impaired growth and lower BMD, whereas elevated InsR signaling (CGL) causes accelerated growth and higher BMD. These patients demonstrate that insulin action through the InsR stimulates direct anabolic effects in bone and indirect actions through the growth hormone (GH)\u2013IGF-1 axis. TBIR patients exhibit abnormalities in the GH axis that resolve when InsR signaling is restored, supporting a causal relationship between InsR and GH axis signaling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad491","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:13:22Z","timestamp":1692274402000},"page":"e96-e106","source":"Crossref","is-referenced-by-count":24,"title":["Insulin Signaling Through the Insulin Receptor Increases Linear Growth Through Effects on Bone and the GH\u2013IGF-1 Axis"],"prefix":"10.1210","volume":"109","author":[{"given":"Marinna C","family":"Okawa","sequence":"first","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M","family":"Tuska","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-0452","authenticated-orcid":false,"given":"Marissa","family":"Lightbourne","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent S","family":"Abel","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Walter","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhai","family":"Dai","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Cochran","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-7382","authenticated-orcid":false,"given":"Rebecca J","family":"Brown","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"issue":"4","key":"2025040315131887400_dgad491-B1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ijo.2011.238","article-title":"Patterns of linear growth and skeletal maturation from birth to 18 years of age in overweight young adults","volume":"36","author":"Johnson","year":"2012","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"2025040315131887400_dgad491-B2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000488865","article-title":"Adolescent undernutrition: global burden, physiology, and nutritional risks","volume":"72","author":"Christian","year":"2018","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"2025040315131887400_dgad491-B3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1210\/clinem\/dgaa510","article-title":"Prospective longitudinal assessment of linear growth and adult height in female adolescents with anorexia nervosa","volume":"106","author":"Modan-Moses","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025040315131887400_dgad491-B4","doi-asserted-by":"crossref","first-page":"e1517","DOI":"10.1542\/peds.2007-2820","article-title":"Determinants of height in adolescent girls with anorexia nervosa","volume":"121","author":"Prabhakaran","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"2025040315131887400_dgad491-B5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4158\/EP13193.OR","article-title":"Advanced bone age and hyperinsulinemia in overweight and obese children","volume":"20","author":"Pinhas-Hamiel","year":"2014","journal-title":"Endocr Pract"},{"issue":"3","key":"2025040315131887400_dgad491-B6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000443735","article-title":"Anorexia nervosa and its associated endocrinopathy in young people","volume":"85","author":"Misra","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"2025040315131887400_dgad491-B7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/jpem-2020-0447","article-title":"Relationship between insulin-like growth factor-1, insulin resistance and metabolic profile with pre-obesity and obesity in children","volume":"34","author":"Jaksic","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"2025040315131887400_dgad491-B8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2265.1984.tb03229.x","article-title":"Fetal growth control: the role of insulin and related peptides","volume":"21","author":"Milner","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2025040315131887400_dgad491-B9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bone.2011.06.018","article-title":"Novel functions for insulin in bone","volume":"50","author":"Fulzele","year":"2012","journal-title":"Bone"},{"key":"2025040315131887400_dgad491-B10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bone.2019.02.021","article-title":"The effect of a high-calorie diet on bone growth is mediated by the insulin receptor","volume":"122","author":"Wu","year":"2019","journal-title":"Bone"},{"issue":"2","key":"2025040315131887400_dgad491-B11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"issue":"12","key":"2025040315131887400_dgad491-B12","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025040315131887400_dgad491-B13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4158\/EP12139.RA","article-title":"Syndromic insulin resistance: models for the therapeutic basis of the metabolic syndrome and other targets of insulin resistance","volume":"18","author":"Gorden","year":"2012","journal-title":"Endocr Pract"},{"issue":"4","key":"2025040315131887400_dgad491-B14","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"issue":"4","key":"2025040315131887400_dgad491-B15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.md.0000133625.73570.54","article-title":"Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective","volume":"83","author":"Musso","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2025040315131887400_dgad491-B16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"issue":"2","key":"2025040315131887400_dgad491-B17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"2025040315131887400_dgad491-B18","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1210\/jc.2014-1353","article-title":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy","volume":"99","author":"Christensen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025040315131887400_dgad491-B19","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.1210\/clinem\/dgab782","article-title":"Long-term effects of metreleptin in Rabson-Mendenhall syndrome on glycemia, growth, and kidney function","volume":"107","author":"Okawa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025040315131887400_dgad491-B20","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1210\/jc.2010-0167","article-title":"Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies","volume":"95","author":"Malek","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040315131887400_dgad491-B21","volume-title":"Radiographic Atlas of Skeletal Development of the Hand and Wrist","author":"Greulich","year":"1959","edition":"2nd ed"},{"issue":"235","key":"2025040315131887400_dgad491-B22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"issue":"239","key":"2025040315131887400_dgad491-B23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"issue":"246","key":"2025040315131887400_dgad491-B24","first-page":"1","article-title":"2000 CDC growth charts for the United States: methods and development","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat"},{"issue":"5","key":"2025040315131887400_dgad491-B25","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025040315131887400_dgad491-B26","doi-asserted-by":"crossref","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","article-title":"Dual energy x-ray absorptiometry body composition reference values from NHANES","volume":"4","author":"Kelly","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"2025040315131887400_dgad491-B27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025040315131887400_dgad491-B28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"8","key":"2025040315131887400_dgad491-B29","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.2337\/diacare.26.8.2426","article-title":"Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients","volume":"26","author":"Yokoyama","year":"2003","journal-title":"Diabetes Care"},{"key":"2025040315131887400_dgad491-B30"},{"key":"2025040315131887400_dgad491-B31"},{"key":"2025040315131887400_dgad491-B32"},{"key":"2025040315131887400_dgad491-B33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mce.2015.01.001","article-title":"High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity","volume":"410","author":"Lecka-Czernik","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2025040315131887400_dgad491-B34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2008-0028","article-title":"Unraveling insulin-like growth factor binding protein-3 actions in human disease","volume":"30","author":"Jogie-Brahim","year":"2009","journal-title":"Endocr Rev"},{"issue":"2","key":"2025040315131887400_dgad491-B35","first-page":"73","article-title":"Regulation of IGFBP-1 in metabolic diseases","volume":"3","author":"Bae","year":"2013","journal-title":"J Lifestyle Med"},{"issue":"3","key":"2025040315131887400_dgad491-B36","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.2004-1501","article-title":"Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men","volume":"90","author":"Liew","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025040315131887400_dgad491-B37","first-page":"872","article-title":"Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes","volume":"79","author":"Brismar","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025040315131887400_dgad491-B38","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/s41467-020-15623-z","article-title":"Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease","volume":"11","author":"Merry","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"2025040315131887400_dgad491-B39","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/cells9091940","article-title":"AMPK-dependent mechanisms but not hypothalamic lipid signaling mediates GH-secretory responses to GHRH and ghrelin","volume":"9","author":"V\u00e1zquez","year":"2020","journal-title":"Cells"},{"issue":"13","key":"2025040315131887400_dgad491-B40","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/febs.14106","article-title":"The energy sensing LKB1-AMPKalpha1 pathway regulates IGF1 secretion and consequent activation of the IGF1R-PKB pathway in primary hepatocytes","volume":"284","author":"Chen","year":"2017","journal-title":"FEBS J"},{"issue":"1","key":"2025040315131887400_dgad491-B41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1479-5876-10-224","article-title":"Human conditions of insulin-like growth factor-I (IGF-I) deficiency","volume":"10","author":"Puche","year":"2012","journal-title":"J Transl Med"},{"key":"2025040315131887400_dgad491-B42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2025040315131887400_dgad491-B43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jcem.85.3.6461","article-title":"Does serum growth hormone (GH) binding protein reflect human GH receptor function?","volume":"85","author":"Amit","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025040315131887400_dgad491-B44","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0026-0495(93)90159-L","article-title":"Regulation of the growth hormone (GH) receptor and GH-binding protein by GH pulsatility","volume":"42","author":"Hochberg","year":"1993","journal-title":"Metabolism"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad491\/51336738\/dgad491.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/1\/e96\/54731746\/dgad491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/1\/e96\/54731746\/dgad491.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T18:01:28Z","timestamp":1743703288000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/1\/e96\/7246018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,18]]},"published-print":{"date-parts":[[2023,12,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad491","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,8,18]]}}}